Acurx Pharmaceuticals, Inc. (ACXP): Insider Trading, Congress Trades & Research | Tormere

ACXP

$1.03+0.98%visit website

Acurx Pharmaceuticals, Inc.

Market Cap

$5M

Live price × SEC shares (Aug 13, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-2.06

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

0.7

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	430	282	341	1,072	2,125
Total operating expenses	2,029	1,617	1,716	2,307	7,669
Operating income	(2,029)	(1,617)	(1,716)	(2,307)	(7,669)
Net income	(1,993)	(1,578)	(1,681)	(2,254)	(7,506)
EPS (basic) ($)	(1.23)		(0.62)	(0.53)	—
EPS (diluted) ($)	(1.23)		(0.62)	(0.53)	—
Weighted avg. shares (basic)	1,626		2,718	4,260
Weighted avg. shares (diluted)	1,626		2,718	4,260

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 21 more quarters, back to Jun 2020, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

Acurx Pharmaceuticals, Inc. (ACXP) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-11-01

From Global Private Credit to Programmable Securities: New to The Street Show #778 Premieres Tonight on Bloomberg Television

Yahoo · 2026-10-31

Acurx Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 12, 2026 Conference Call and Provide Business Update

Yahoo · 2026-10-26

Before markets open, Acurx will discuss its third-quarter results Nov. 12.

Stock Titan · 2026-10-26

From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television

Yahoo · 2026-10-24

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga · 2026-10-22

Acurx Announces Publication in ASM Confirming Data on its DNA pol IIIC Inhibitor Pipeline of Antibiotics Demonstrating a Potential Microbiome-Sparing Class Effect

Yahoo · 2026-10-21

Acurx Pharmaceuticals Takes Its Antibiotics Story Global Through a 12-Month Series with New to The Street

Yahoo · 2026-10-05

Acurx Pharmaceuticals Announces First Patient Enrolled in PATHFINDER Clinical Trial of Ibezapolstat in Multiply-Recurrent C. difficile Infection

Yahoo Finance · 2026-09-29

New to The Street Broadcasts Tonight at 6:30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global

Yahoo Finance · 2026-09-19

Acurx Announces Presentation of a Scientific Poster at the Premier International C. difficile Symposium (ICDS) Demonstrating Superior In Vitro Kill Kinetics of Ibezapolstat vs. Vancomycin and Fidaxomicin (Standards of Care) in Clostridioides difficile and Vancomycin-Resistant Enterococcus Co-Cultures

Yahoo Finance · 2026-09-14

Acurx Pharmaceuticals Inc (ACXP) (Q2 2026) Earnings Call Highlights: FDA Signals Potential ...

Yahoo Finance · 2026-08-21

Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update

Yahoo Finance · 2026-08-14

Earnings call transcript: Acurx beats Q2 2026 EPS forecast but shares slip premarket

Investing.com · 2026-08-14

ACXP Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-25

Informational purposes only, not investment advice.